Literature DB >> 23461248

Is the type of chronic pulmonary infection a determinant of lung function outcomes in adult patients with cystic fibrosis?

A J Lopes1, T T Mafort, A de Sá Ferreira, M C Santos de Castro, M Cássia de Firmida, E de Andrade Marques.   

Abstract

BACKGROUND AND AIM: Lung function abnormalities are the main factors responsible for the high mortality of cystic fibrosis (CF) patients. It is not yet clear whether Burkholderia cepacia infection causes more pronounced loss of lung function than pseudomonas aeruginosa infection. Our primary objective was to compare the lung function of adult CF patients with different chronic pulmonary infections. Our second objective was to compare the microbiology using patients' genetic status.
METHODS: Fifty-two adult CF patients were divided into 3 groups according to their chronic pulmonary infection profile. All subjects underwent clinical evaluation, pulmonary function tests (PFT) and genetic analysis.
RESULTS: The PFT parameters of chronically infected patients were significantly different from those of subjects without pulmonary infection (p < 0.0001). FVC was significantly more altered in patients infected with B. cepacia complex (p < 0.0001); in contrast, FEF25-75% was significantly more altered in patients with P. aeruginosa infection (p < 0.0001). In the groups with chronic P. aeruginosa infection and chronic B. cepacia complex infection, 58.1% and 10% of patients were homozygous for AF508, respectively. In addition to chronic infections, pancreatic insufficiency was also associated with lung function deterioration.
CONCLUSION: Chronic pulmonary infection and pancreatic insufficiency are critical processes in lung function deterioration in adult CF patients. Although chronic B. cepacia complex infection causes a more pronounced lung volume reduction, chronic P. aeruginosa infection causes a more pronounced obstruction of small airways. Our results also suggest that deltaF508-homozygous patients are more susceptible to chronic P. aeruginosa infection.

Entities:  

Mesh:

Year:  2012        PMID: 23461248     DOI: 10.4081/monaldi.2012.145

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  4 in total

1.  Impact of different etiologies of bronchiectasis on the pulmonary function tests.

Authors:  Agnaldo José Lopes; Gustavo Bittencourt Camilo; Sara Lucia Silveira de Menezes; Fernando Silva Guimarães
Journal:  Clin Med Res       Date:  2014-11-07

2.  Sialylation of outer membrane porin protein D: a mechanistic basis of antibiotic uptake in Pseudomonas aeruginosa.

Authors:  Biswajit Khatua; Jeremy Van Vleet; Biswa Pronab Choudhury; Rama Chaudhry; Chitra Mandal
Journal:  Mol Cell Proteomics       Date:  2014-03-18       Impact factor: 5.911

3.  Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis.

Authors:  M C Firmida; R H V Pereira; E A S R Silva; E A Marques; A J Lopes
Journal:  Braz J Med Biol Res       Date:  2016-02-23       Impact factor: 2.590

4.  Azithromycin may antagonize inhaled tobramycin when targeting Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Jerry A Nick; Samuel M Moskowitz; James F Chmiel; Anna V Forssén; Sun Ho Kim; Milene T Saavedra; Lisa Saiman; Jennifer L Taylor-Cousar; David P Nichols
Journal:  Ann Am Thorac Soc       Date:  2014-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.